Articles
Antidotes or Reversibility Agents – Are they Needed?
Published:
01 May 2015
Citation:
Arrhythmia & Electrophysiology Review 2015;4(1 Suppl 1):1-12
How to Choose Between NOACs
Published:
01 May 2015
Citation:
Arrhythmia & Electrophysiology Review 2015;4(1 Suppl 1):1-12
Corrigendum to: Preventive Ventricular Tachycardia Ablation in Patients with Ischaemic Cardiomyopathy: Meta-analysis of Randomised Trials
Citation:
Arrhythmia & Electrophysiology Review 2019;8(4):304.
Ivabradine and AF: Coincidence, Correlation or a New Treatment?
Citation:
Arrhythmia & Electrophysiology Review 2019;8(4):300–3.
Arrhythmias from the Right Ventricular Moderator Band: Diagnosis and Management
Citation:
Arrhythmia & Electrophysiology Review 2019;8(4):294–9.
High-power, Short-duration Radiofrequency Ablation for the Treatment of AF
Citation:
Arrhythmia & Electrophysiology Review 2019;8(4):265–72.
Idiopathic Left Ventricular Tachycardia Originating in the Left Posterior Fascicle
Citation:
Arrhythmia & Electrophysiology Review 2019;8(4):249–54.
Challenges Associated with Interpreting Mechanisms of AF
Citation:
Arrhythmia & Electrophysiology Review 2019;8(4):273–84.
Unmasking Adenosine: The Purinergic Signalling Molecule Critical to Arrhythmia Pathophysiology and Management
Citation:
Arrhythmia & Electrophysiology Review 2019;8(4):240–8.
Multimodality Imaging to Guide Ventricular Tachycardia Ablation in Patients with Non-ischaemic Cardiomyopathy
Citation:
Arrhythmia & Electrophysiology Review 2019;8(4):255–64.